However, according to our knowledge, our present study is the first to assess the serum concentrations of chemokine CXCL12 in relation to its specific receptor CXCR4 and classical tumor markers for EC (CEA and SCC-Ag) as well as marker of inflammatory states—C-reactive protein (CRP). Here, CXCR4 is linked to neoplasm.